2017年9月28日星期四

Ipsum Quia Prognose–487 Dolor Sit Amet–16

Ipsum Quia Prognose–487 Dolor Sit Amet–16

AR CAR, MAR MAR - Entzündliche Augenerkrankungen, 2014 - books.google.com
Page 416. 399 10 1.1 10.15. 3 10.15. 4 10.15. 5 10.15. 6 10.15. 7 10.15. 8 1.1. 1 10.16 10.16.
1 10.16. 2 10.16. 3 10.16. 4 10.16. 5 10.16. 6 10.16. 7 10.16. 8 10.17 10.17. 1 10.17. 2 10.17.
3 10.17. 4 10.17. 5 10.17. 6 10.17. 7 10.17. 8 10.18 10.18. 1 10.18. 2 10.18. ...


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论